LEADER 01447oam  2200421 a 450 
001 9910704366003321
005 20130124091012.0
035   $a(CKB)5470000002440023
035   $a(OCoLC)823391127
035   $a(EXLCZ)995470000002440023
100   $a20130105d2012      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMedicare Part D coverage gap$b[electronic resource] $ediscount program effects and brand-name drug price trends : report to congressional requesters
210  1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2012]
215   $a1 online resource (iii, 41 pages) $ccolor illustrations
300   $aTitle from title screen (viewed on Dec. 31, 2012).
300   $a"September 2012."
300   $aQR code for online version of document included on title page.
300   $a"GAO-12-914."
320   $aIncludes bibliographical references.
517   $aMedicare Part D coverage gap 
606   $aMedicare
606   $aPharmaceutical services insurance$zUnited States
606   $aDrugs$xPrices$zUnited States
615  0$aMedicare.
615  0$aPharmaceutical services insurance
615  0$aDrugs$xPrices
801  0$bVVK
801  1$bVVK
801  2$bGPO
906   $aBOOK
912   $a9910704366003321
996   $aMedicare Part D coverage gap$93533580
997   $aUNINA